Western Blotting Market Size to grow at 6.7% CAGR up to 2026- Leading Key Players are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany)

According to the new market research report study titled 'Western Blotting Market to 2026 - Global Analysis and Forecasts by Product, Application, End User and Geography. the global Western Blotting Market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. The report includes a variety of in-depth research studies on various aspects of the global Western Blotting market.

Some of the leading players operating in the western blotting market are Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany).

Download Sample PDF Western Blotting Report Copy @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711&utm_source=OPenpr&utm_medium=referral

BIO-RAD LABORATORIES, INC. (US)
Bio-Rad Laboratories is a leading player in the western blotting market. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company's leading position in the market can be attributed to its wide customer base

Western Blotting Market Dynamics

Technological advancements
In recent years, the western blotting market has witnessed a significant number of new product launches by leading players. These products are developed to increase the accuracy and efficiency of and reduce the processing time of western blotting. Leading companies such as Thermo Fisher Scientific, Inc. (US), Bio-Techne Corporation (US), and Azure Biosystems, Inc. (US) have introduced several next-generation western blotting instruments in the last few years.

Emergence of alternative technologies
Western blotting is one of the most widely used protein analysis techniques. It is extensively used by researchers in the biotechnology, pharmaceutical, and diagnostics industries. However, the rising demand for enhancements in terms of ease of use, speed, accuracy, consistency, sensitivity, and the ability to quantify results and handle more samples has resulted in a shift toward alternative technologies. Antibody-based assays such as ELISA and lateral flow immunoassays (LFIA) are the major alternatives to western blotting. Multiplexed bead assays such as Luminex, array-based approaches such as Meso Scale Discovery, and line immunoassays are also likely to impact the demand for western blotting, especially in commercial sectors like diagnostics.

Emerging economies
The Asia Pacific, Latin America, and the Middle East & Africa are expected to offer potential growth opportunities to market players in the coming years due to the diversified healthcare markets in these regions and increasing R&D initiatives to develop innovative proteomic and genomic techniques along with the development of personalized medicine. Additionally, developments in research infrastructure and the low-cost manufacturing advantage of emerging APAC countries are expected to encourage market players to invest in this region in the coming years. For instance, in June 2019, Merck KGaA (Germany) introduced a national campus tour in China for the company's first mobile protein research laboratory. The national tour will cover 20 college and biotech campuses in 13 cities across the country, including Beijing, Chengdu, Guangzhou, and Wuhan.

Requirement of high procedural efficiency for accurate results
Western blotting requires a complex combination of analytical knowledge, extensive manual handling, dexterity, and strict adherence to protocols to achieve reliable results. Failure rates, however, can be as high as 25%, and data variations between different users can be as high as 35-40%. High efficiency is required for producing and analyzing the data. This efficiency in results is achieved to an extent through the automation of western blotting instruments. Furthermore, it requires a rigorous methodology to produce quantitative data. According to a survey by Bio-Rad Laboratories, nearly 41% of researchers believe that their western blots fail to achieve accurate results a quarter of the time primarily due to incomplete or flawed protocols. Western blots are sensitive to the quantity and purity of samples used, and small deviations can lead to erroneous and variable inferences.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711&utm_source=OPenpr&utm_medium=referral

Western Blotting - MARKET SEGMENTATION

The study categorizes the western blotting market into the following segments and subsegments:

Western Blotting Market, by Product
• Consumables
• Instruments

Western Blotting Market, by Application
• Biomedical Research
• Clinical Diagnostics
• Agricultural Applications
• Other Applications

Western Blotting Market, by End User
• Academic & Research Institutes
• Biopharmaceutical & Biotechnology
Companies
• Hospitals & Diagnostic Laboratories
• Other End Users

Western Blotting Market, by Region
• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Recent Developments

• In September 2021, PerkinElmer, Inc. (US) acquired BioLegend (US), a leading provider of life science antibodies and reagents, including primary antibodies and western blot secondary reagents. This acquisition enhances the company's existing western blotting product portfolio.

• In August 2021, Abcam Plc (UK) acquired BioVision Inc. (US), a global supplier of life science research tools for research, diagnostics, and drug discovery. The company is a leading provider of biochemical and cell-based assays and produces a wide portfolio of other products, including recombinant proteins, antibodies, enzymes, and biochemical compounds for immunoassay technologies such as western blotting

• In April 2021, Bio-Techne Corporation (US) launched Abby, a next-generation chemiluminescence system that automates traditional western blotting

Buy Complete Western Blotting Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=235810711&utm_source=OPenpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.